Private Equity

Updated:

Rejuveron Life Sciences

Rejuveron Life Sciences is a private equity firm based in Zurich, Switzerland. It pursues a Venture Capital strategy. The firm has a team of three, including...

Rejuveron Life Sciences logo

Rejuveron Life Sciences

Rejuveron Life Sciences is a private equity firm based in Zurich, Switzerland. It pursues a Venture Capital strategy. The firm has a team of three, including two investment professionals.

General information

Firm type

Private Equity

Location

Region

Europe

Country

Switzerland

City

Baar

Corporate office

Neuhofstrasse 12, CH-6340 Baar, Switzerland

Sector focus

Healthcare ServicesAI/ML

Frequently asked questions

Who runs investment decisions at Rejuveron Life Sciences?

Rejuveron does not publicly identify any principals, investment committee members, or senior leadership. All public-facing materials operate through the Centenara Labs brand, which names only a contact address and phone number. No LinkedIn profile or third-party reporting fills the gap.

How does Rejuveron source its therapeutic programs?

The firm describes building its pipeline by founding new companies around promising discoveries in aging research, rather than solely evaluating external in-licensing opportunities. Its scientific leadership translates hallmarks-of-aging biology into targeted therapeutic concepts, which are then funded into early-stage companies.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Baar Private Equity profiles